Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The current use of neuromodulation for bladder dysfunction.

N D Sherman1, C L Amundsen

  • 1Division of Urology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ, USA. shermane@umdnj.edu

Minerva Ginecologica
|September 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence.

The Journal of urology·2017
Same author

Pelvic organ prolapse: a review of the current literature.

Minerva ginecologica·2007
Same author

Bilateral uterosacral ligament vaginal vault suspension with site-specific endopelvic fascia defect repair for treatment of pelvic organ prolapse.

American journal of obstetrics and gynecology·2000
Same author

Outcome in 104 pubovaginal slings using freeze-dried allograft fascia lata from a single tissue bank.

Urology·2000
Same author

Variations in strategy for the treatment of urethral obstruction after a pubovaginal sling procedure.

The Journal of urology·2000
Same author

Bladder endometriosis: conservative management.

The Journal of urology·2000
Same journal

High grade cervical intraepithelial neoplasia positive biopsy: the importance of accurate pre-operative workup.

Minerva ginecologica·2021
Same journal

Efficacy and safety of a novel vaginal medical device in recurrent bacterial vaginosis: a multicenter clinical trial.

Minerva ginecologica·2020
Same journal

[Advisory Board Italiano sulla sindrome dell'ovaio policistico (PCOS): dalle osservazioni all'esperienze cliniche sull'uso del mioinositolo (MYO) e dell'acido alfa-lipoico (ALA) per migliorare i quadri della sindrome].

Minerva ginecologica·2020
Same journal

Update on new imaging technologies in sentinel node detection.

Minerva ginecologica·2020
Same journal

Postoperative pelvic dysfunctions associated with the reconstruction of the pelvic floor.

Minerva ginecologica·2020
Same journal

The role of sentinel-node biopsy in ovarian cancer.

Minerva ginecologica·2020
See all related articles

Sacral neuromodulation uses electrical stimulation to treat bladder dysfunction like urinary urgency and incontinence. This review covers its applications, patient selection, techniques, outcomes, and complications.

Area of Science:

  • Urology
  • Neuroscience
  • Biomedical Engineering

Background:

  • Neuromodulation, using electrical stimulation, is increasingly used to manage organ function.
  • Advances in technology and understanding of micturition physiology have driven neuromodulation for urinary issues.
  • Sacral neuromodulation, stimulating the S3 foramen, is the primary method for bladder neuromodulation.

Purpose of the Study:

  • To review the current indications for sacral neuromodulation.
  • To discuss patient selection, implantation techniques, and outcomes.
  • To explore complications and alternative neuromodulation methods for bladder dysfunction.

Main Methods:

  • Literature review of sacral neuromodulation.
  • Analysis of current clinical indications and patient selection criteria.

Related Experiment Videos

  • Evaluation of implantation techniques, outcomes, and complication data.

    • Main Results:

    • Sacral neuromodulation is effective for urinary urgency/frequency, urge incontinence, and non-obstructive urinary retention.
    • Specific patient selection criteria and implantation techniques influence outcomes.
    • Complications are generally manageable, but awareness is crucial.

    Conclusions:

    • Sacral neuromodulation is a valuable treatment option for various lower urinary tract symptoms.
    • Further research into optimizing techniques and exploring alternative neuromodulation methods is warranted.
    • This review provides a comprehensive overview for clinicians considering neuromodulation therapies.